The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

European regulators have greenlit a twice-yearly injection to prevent HIV that has been hailed as a game-changer in the ...

Needham has a $133 price target on the stock, representing an upside of about 17.5% to the stock’s closing price on Thursday.

HIV antivirals may be the key to stopping HTLV-1, a deadly virus with no cure. In a decade-long study, researchers ...

Northwell Health is now offering a new injection that promises to reduce the risk of HIV and AIDS. Doctors say it will combat ...

Similarly, Gilead has provided nearly $35.8 million in total philanthropic support for Black women-led and/or Black ...

Amid rising HIV/AIDS cases, Meghalaya to mandate pre-marital testing, starting in East Khasi Hills, citing sexual ...

DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

A federal judge extended a block on an Idaho law that uses an applicant’s immigration status to determine whether they’re ...

Chicago-area groups that support LGBTQ+ individuals are navigating an uncertain landscape while bracing for federal funding ...

Arizona organizations are working hard to provide testing and education for HIV/AIDS programs, but despite medical ...